Skip to Main Content

Advertisement

Umbrella Alt Text
header search
Search
Advanced Search
Skip Nav Destination

AEE788: A Dual Family Epidermal Growth Factor Receptor/ErbB2 and Vascular Endothelial Growth Factor Receptor Tyrosine Kinase Inhibitor with Antitumor and Antiangiogenic Activity

Cancer Res (2004) 64 (14): 4931–4941.
This article has been cited by the following articles in journals that are participating in CrossRef Cited-by Linking.
A high-throughput cigarette smoke-treated bronchosphere model for disease-relevant phenotypic compound screening
  • Pranjali Beri
  • Young Jae Woo
  • Katie Schierenbeck
  • Kaisheng Chen
  • S. Whitney Barnes
  • Olivia Ross
  • Douglas Krutil
  • Doug Quackenbush
  • Bin Fang
  • John Walker
  • William Barnes
  • Erin Quan Toyama
  • Aran Singanayagam
PLOS ONE (2023) 18 (6): e0287809.
Benzimidazole-linked pyrazolo[1,5-a]pyrimidine conjugates: synthesis and detail evaluation as potential anticancer agents
  • Chandrakant Bagul
  • Garikapati Koteswara Rao
  • Immadi Veena
  • Ravindra Kulkarni
  • Jaki R. Tamboli
  • Ravikumar Akunuri
  • Siddiq Pasha Shaik
  • Manika Pal-Bhadra
  • Ahmed Kamal
Molecular Diversity (2023) 27 (3): 1185.
Palladium-Catalyzed Highly Regioselective C6 Arylation of Pyrrolo[2,3-d]pyrimidine Derivatives with Arylboronic Acids
  • Min Liu
  • Chunwei Shen
  • Ting Tang
  • Chenhong Pan
  • Mingrui Liu
  • Xingxian Zhang
Organic Letters (2023) 25 (15): 2637.
Fluorescence Imaging of Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor Resistance in Non-Small Cell Lung Cancer
  • Marisa L. Martin-Fernandez
Cancers (2022) 14 (3): 686.
Pseudokinase NRP1 facilitates endocytosis of transferrin in the African trypanosome
  • Gaurav Kumar
  • Bryanna Thomas
  • Kojo Mensa-Wilmot
Scientific Reports (2022) 12 (1)
Structure-Based Virtual Screening, Molecular Docking, and Molecular Dynamics Simulation of VEGF inhibitors for the clinical treatment of Ovarian Cancer
  • Sourav Mukherjee
  • Mohnad Abdalla
  • Manasi Yadav
  • Maddala Madhavi
  • Anushka Bhrdwaj
  • Ravina Khandelwal
  • Leena Prajapati
  • Aravind Panicker
  • Aashish Chaudhary
  • Ashraf Albrakati
  • Tajamul Hussain
  • Anuraj Nayarisseri
  • Sanjeev Kumar Singh
Journal of Molecular Modeling (2022) 28 (4)
Current updates on EGFR and HER2 tyrosine kinase inhibitors for the breast cancer
  • Prasad Sanjay Dhiwar
  • Gurubasavaraja Swamy Purwarga Matada
  • Nulgumnalli Manjunathaiah Raghavendra
  • Abhishek Ghara
  • Ekta Singh
  • Nahid Abbas
  • Ganesh Sakaram Andhale
  • Ganesh Prasad Shenoy
  • Pujan Sasmal
Medicinal Chemistry Research (2022) 31 (9): 1401.
Glioblastoma: Current Status, Emerging Targets, and Recent Advances
  • Amandeep Thakur
  • Chetna Faujdar
  • Ram Sharma
  • Sachin Sharma
  • Basant Malik
  • Kunal Nepali
  • Jing Ping Liou
Journal of Medicinal Chemistry (2022) 65 (13): 8596.
Paradoxical activation of c-Src as a drug-resistant mechanism
  • Makio Higuchi
  • Kenichi Ishiyama
  • Masahiro Maruoka
  • Ryosuke Kanamori
  • Akifumi Takaori-Kondo
  • Naoki Watanabe
Cell Reports (2021) 34 (12): 108876.
Casein kinase TbCK1.2 regulates division of kinetoplast DNA, and movement of basal bodies in the African trypanosome
  • Catherine Sullenberger
  • Benjamin Hoffman
  • Justin Wiedeman
  • Gaurav Kumar
  • Kojo Mensa-Wilmot
  • Ben L. Kelly
PLOS ONE (2021) 16 (4): e0249908.
Potentiating Therapeutic Effects of Epidermal Growth Factor Receptor Inhibition in Triple-Negative Breast Cancer
  • Kyu Sic You
  • Yong Weon Yi
  • Jeonghee Cho
  • Jeong-Soo Park
  • Yeon-Sun Seong
Pharmaceuticals (2021) 14 (6): 589.
Complementarity principle in terms of electron density for the study of EGFR complexes
  • Shivananda Kandagalla
  • Hrvoje Rimac
  • Vladimir A Potemkin
  • Maria A Grishina
Future Medicinal Chemistry (2021) 13 (10): 863.
Review on Epidermal Growth Factor Receptor (EGFR) Structure, Signaling Pathways, Interactions, and Recent Updates of EGFR Inhibitors
  • Dima A. Sabbah
  • Rima Hajjo
  • Kamal Sweidan
Current Topics in Medicinal Chemistry (2020) 20 (10): 815.
Molecular dynamics simulation and 3D-pharmacophore analysis of new quinoline-based analogues with dual potential against EGFR and VEGFR-2
  • Neda Fayyazi
  • Afshin Fassihi
  • Somayeh Esmaeili
  • Salman Taheri
  • Jahan B. Ghasemi
  • Lotfollah Saghaie
International Journal of Biological Macromolecules (2020) 142: 94.
Co-delivery of Sorafenib and CRISPR/Cas9 Based on Targeted Core–Shell Hollow Mesoporous Organosilica Nanoparticles for Synergistic HCC Therapy
  • Bing-Chen Zhang
  • Bang-Yue Luo
  • Jun-Jie Zou
  • Peng-Yu Wu
  • Jia-Li Jiang
  • Jing-Qing Le
  • Rui-Rui Zhao
  • Lu Chen
  • Jing-Wei Shao
ACS Applied Materials & Interfaces (2020) 12 (51): 57362.
In silico Identification of Peptide as Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors in Lung Cancer Treatment
  • Shabrina N. Imana
  • Eka G. Ningsih
  • Usman S.F. Tambunan
Pakistan Journal of Biological Sciences (2020) 23 (4): 567.
Antiproliferative and apoptotic effects of indole derivative, N-(2-hydroxy-5-nitrophenyl (4′-methylphenyl) methyl) indoline in breast cancer cells
  • Suresh Palanivel
  • Akshaya Murugesan
  • Kumar Subramanian
  • Olli Yli-Harja
  • Meenakshisundaram Kandhavelu
European Journal of Pharmacology (2020) 881: 173195.
Advances in the strategies for designing receptor-targeted molecular imaging probes for cancer research
  • Young Ji Ko
  • Woo Jun Kim
  • Kwangmeyung Kim
  • Ick Chan Kwon
Journal of Controlled Release (2019) 305: 1.
Targeting the non-canonical roles of PCNA modifies and increases the response to targeted anti-cancer therapy
  • Caroline K. Søgaard
  • Anala Nepal
  • Voin Petrovic
  • Animesh Sharma
  • Nina-Beate Liabakk
  • Tonje S. Steigedal
  • Marit Otterlei
Oncotarget (2019) 10 (68): 7185.
Novel pyrazolo[3,4-d]pyrimidines: design, synthesis, anticancer activity, dual EGFR/ErbB2 receptor tyrosine kinases inhibitory activity, effects on cell cycle profile and caspase-3-mediated apoptosis
  • Mai Maher
  • Asmaa E. Kassab
  • Ashraf F. Zaher
  • Zeinab Mahmoud
Journal of Enzyme Inhibition and Medicinal Chemistry (2019) 34 (1): 532.
Multi-targeted kinase inhibition alleviates mTOR inhibitor resistance in triple-negative breast cancer
  • Jichao He
  • Ronan P. McLaughlin
  • Vera van der Noord
  • John A. Foekens
  • John W. M. Martens
  • Gerard van Westen
  • Yinghui Zhang
  • Bob van de Water
Breast Cancer Research and Treatment (2019) 178 (2): 263.
N,N′-diaryl urea derivatives: Molecular docking, molecular properties prediction and anticancer evaluation
  • Zühal Kilic-Kurt
  • Filiz Bakar-Ates
  • Mehmet Bahat
Journal of Molecular Structure (2019) 1193: 239.
Kinase-Inactivated EGFR Is Required for the Survival of Wild-Type EGFR-Expressing Cancer Cells Treated with Tyrosine Kinase Inhibitors
  • Rintu Thomas
  • Shivangi Srivastava
  • Rajasekhara Reddy Katreddy
  • Jason Sobieski
  • Zhang Weihua
International Journal of Molecular Sciences (2019) 20 (10): 2515.
Receptor tyrosine kinases (RTKs) in breast cancer: signaling, therapeutic implications and challenges
  • Ramesh Butti
  • Sumit Das
  • Vinoth Prasanna Gunasekaran
  • Amit Singh Yadav
  • Dhiraj Kumar
  • Gopal C. Kundu
Molecular Cancer (2018) 17 (1)
C–H Imidation of 7-Deazapurines
  • Nazarii Sabat
  • Lenka Poštová Slavětínská
  • Blanka Klepetářová
  • Michal Hocek
ACS Omega (2018) 3 (4): 4674.
Structural insights into drug development strategy targeting EGFR T790M/C797S
  • Su-Jie Zhu
  • Peng Zhao
  • Jiao Yang
  • Rui Ma
  • Xiao-E Yan
  • Sheng-Yong Yang
  • Jing-Wen Yang
  • Cai-Hong Yun
Oncotarget (2018) 9 (17): 13652.
Crosstalk between VEGFR and other receptor tyrosine kinases for TKI therapy of metastatic renal cell carcinoma
  • Yongchang Lai
  • Zhijian Zhao
  • Tao Zeng
  • Xiongfa Liang
  • Dong Chen
  • Xiaolu Duan
  • Guohua Zeng
  • Wenqi Wu
Cancer Cell International (2018) 18 (1)
Novel SEC61G–EGFR Fusion Gene in Pediatric Ependymomas Discovered by Clonal Expansion of Stem Cells in Absence of Exogenous Mitogens
  • Tiziana Servidei
  • Daniela Meco
  • Valentina Muto
  • Alessandro Bruselles
  • Andrea Ciolfi
  • Nadia Trivieri
  • Matteo Lucchini
  • Roberta Morosetti
  • Massimiliano Mirabella
  • Maurizio Martini
  • Massimo Caldarelli
  • Anna Lasorella
  • Marco Tartaglia
  • Riccardo Riccardi
Cancer Research (2017) 77 (21): 5860.
Efficacy of targeted drugs in germ cell cancer cell lines with differential cisplatin sensitivity
  • Judith Schaffrath
  • Hans-Joachim Schmoll
  • Wieland Voigt
  • Lutz P. Müller
  • Carsten Müller-Tidow
  • Thomas Mueller
  • Aamir Ahmad
PLOS ONE (2017) 12 (6): e0178930.
Fluorescent Affibody Molecule Administered In Vivo at a Microdose Level Labels EGFR Expressing Glioma Tumor Regions
  • Ana Luiza Ribeiro de Souza
  • Kayla Marra
  • Jason Gunn
  • Kimberley S. Samkoe
  • P. Jack Hoopes
  • Joachim Feldwisch
  • Keith D. Paulsen
  • Brian W. Pogue
Molecular Imaging and Biology (2017) 19 (1): 41.
Identification of new pyrrolo[2,3- d ]pyrimidines as Src tyrosine kinase inhibitors in vitro active against Glioblastoma
  • Francesca Musumeci
  • Anna Lucia Fallacara
  • Chiara Brullo
  • Giancarlo Grossi
  • Lorenzo Botta
  • Pierpaolo Calandro
  • Mario Chiariello
  • Miroslava Kissova
  • Emmanuele Crespan
  • Giovanni Maga
  • Silvia Schenone
European Journal of Medicinal Chemistry (2017) 127: 369.
AEE788 Inhibits Basal Body Assembly and Blocks DNA Replication in the African Trypanosome
  • Catherine Sullenberger
  • Daniel Piqué
  • Yuko Ogata
  • Kojo Mensa-Wilmot
Molecular Pharmacology (2017) 91 (5): 482.
Investigation of Heck coupling on 6-bromo[2,3-d]thienopyrimidines for construction of new EGFR inhibitor lead structures
  • F. Bysting
  • S. Bugge
  • E. Sundby
  • B. H. Hoff
RSC Advances (2017) 7 (30): 18569.
Cell type- and density-dependent effect of 1 T static magnetic field on cell proliferation
  • Lei Zhang
  • Xinmiao Ji
  • Xingxing Yang
  • Xin Zhang
Oncotarget (2017) 8 (8): 13126.
Small Molecule Kinase Inhibitors for the Treatment of Brain Cancer
  • Timothy P. Heffron
Journal of Medicinal Chemistry (2016) 59 (22): 10030.
Balancing potency, metabolic stability and permeability in pyrrolopyrimidine-based EGFR inhibitors
  • Jin Han
  • Silje Henriksen
  • Kristin G. Nørsett
  • Eirik Sundby
  • Bård Helge Hoff
European Journal of Medicinal Chemistry (2016) 124: 583.
Molecular Dynamics Analysis of Binding of Kinase Inhibitors to WT EGFR and the T790M Mutant
  • Jiyong Park
  • Joseph J. McDonald
  • Russell C. Petter
  • K. N. Houk
Journal of Chemical Theory and Computation (2016) 12 (4): 2066.
C–H Phosphonation of Pyrrolopyrimidines: Synthesis of Substituted 7- and 9-Deazapurine-8-phosphonate Derivatives
  • Nazarii Sabat
  • Lenka Poštová Slavětínská
  • Blanka Klepetářová
  • Michal Hocek
The Journal of Organic Chemistry (2016) 81 (19): 9507.
Chiral 6-aryl-furo[2,3-d]pyrimidin-4-amines as EGFR inhibitors
  • Jin Han
  • Svein Jacob Kaspersen
  • Sondre Nervik
  • Kristin G. Nørsett
  • Eirik Sundby
  • Bård Helge Hoff
European Journal of Medicinal Chemistry (2016) 119: 278.
Identification of gefitinib off-targets using a structure-based systems biology approach; their validation with reverse docking and retrospective data mining
  • Nidhi Verma
  • Amit Kumar Rai
  • Vibha Kaushik
  • Daniela Brünnert
  • Kirti Raj Chahar
  • Janmejay Pandey
  • Pankaj Goyal
Scientific Reports (2016) 6 (1)
Mechanistic Insights into Molecular Targeting and Combined Modality Therapy for Aggressive, Localized Prostate Cancer
  • Alan Dal Pra
  • Jennifer A. Locke
  • Gerben Borst
  • Stephane Supiot
  • Robert G. Bristow
Frontiers in Oncology (2016) 6
Truncated structures used in search for new lead compounds and in a retrospective analysis of thienopyrimidine-based EGFR inhibitors
  • Steffen Bugge
  • Ingri Ullestad Moen
  • Kent-Ove Kragseth Sylte
  • Eirik Sundby
  • Bård Helge Hoff
European Journal of Medicinal Chemistry (2015) 94: 175.
Identification of Glioblastoma Phosphotyrosine-Containing Proteins with Two-Dimensional Western Blotting and Tandem Mass Spectrometry
  • Tianyao Guo
  • Xiaowei Wang
  • Maoyu Li
  • Haiyan Yang
  • Ling Li
  • Fang Peng
  • Xianquan Zhan
BioMed Research International (2015) 2015: 1.
Simultaneous Inhibition of EGFR/VEGFR and Cyclooxygenase-2 Targets Stemness-Related Pathways in Colorectal Cancer Cells
  • Araceli Valverde
  • Jon Peñarando
  • Amanda Cañas
  • Laura M. López-Sánchez
  • Francisco Conde
  • Vanessa Hernández
  • Esther Peralbo
  • Chary López-Pedrera
  • Juan de la Haba-Rodríguez
  • Enrique Aranda
  • Antonio Rodríguez-Ariza
  • Daotai Nie
PLOS ONE (2015) 10 (6): e0131363.
Inhibition of MDA-MB-231 breast cancer cell migration and invasion activity by andrographolide via suppression of nuclear factor-κB-dependent matrix metalloproteinase-9 expression
  • ZANJING ZHAI
  • XINHUA QU
  • HAOWEI LI
  • ZHENGXIAO OUYANG
  • WEI YAN
  • GUANGWANG LIU
  • XUQIANG LIU
  • QIMING FAN
  • TINGTING TANG
  • KERONG DAI
  • AN QIN
Molecular Medicine Reports (2015) 11 (2): 1139.
Modification of Pyrrolo[2,3‐d]pyrimidines by C–H Borylation Followed by Cross‐Coupling or Other Transformations: Synthesis of 6,8‐Disubstituted 7‐Deazapurine Bases
  • Martin Klečka
  • Lenka Poštová Slavětínská
  • Michal Hocek
European Journal of Organic Chemistry (2015) 2015 (36): 7943.
Involvement of de novo synthesized palmitate and mitochondrial EGFR in EGF induced mitochondrial fusion of cancer cells
  • Lakshmi Reddy Bollu
  • Jiangong Ren
  • Alicia Marie Blessing
  • Rajasekhara Reddy Katreddy
  • Guang Gao
  • Lei Xu
  • Jinrong Wang
  • Fei Su
  • Zhang Weihua
Cell Cycle (2014) 13 (15): 2415.
HER2/neu: an increasingly important therapeutic target. Part 1: basic biology & therapeutic armamentarium
  • Edward L Nelson
Clinical Investigation (2014) 4 (7): 649.
Small Molecule Tyrosine Kinase Inhibitors of ErbB2/HER2/Neu in the Treatment of Aggressive Breast Cancer
  • Richard Schroeder
  • Cheryl Stevens
  • Jayalakshmi Sridhar
Molecules (2014) 19 (9): 15196.
Small-molecule clinical trial candidates for the treatment of glioma
  • Saurabh Prabhu
  • Frederick Harris
  • Robert Lea
  • Timothy J. Snape
Drug Discovery Today (2014) 19 (9): 1298.
  • Online ISSN 1538-7445
  • Print ISSN 0008-5472

AACR Journals

 

 

  • Copyright © 2023 by the American Association for Cancer Research.
Close Modal
This Feature Is Available To Subscribers Only

or Create an Account

Close Modal
Close Modal
This site uses cookies. By continuing to use our website, you are agreeing to our privacy policy.
Accept